We Want to Know is meant to aid clinicians, rather than providing them with additional work. A variety of resources will encourage patients and family members to report concerns about serious breakdowns. These concerns will be addressed by experienced real-time response navigators and safety experts who help resolve patients’ problems. The program will also give providers more real-time feedback about patients’ care experience.

 

 

 

 

Why encourage speaking up? 

The We Want To Know program is a collaborative research project being conducted at MedStar Health. It is an intensive, multimodal campaign designed to encourage MedStar patients to speak up, and strategies for providing real-time responses to patients’ concerns. 

 

  • Patients may harbor misconceptions

  • Patients may have valuable information

  • Increase quality of care

  • Improve patient experience

  • Increase provider satisfaction

  • Decrease likelihood of malpractice claims 

 

Materials explaining the We Want to Know hotline and program information will be distributed to patients and their families.

We hope that you will embrace We Want to Know as an important effort in our journey to high reliability. The data gathered through We Want to Know has the potential to aid individual departments and programs, in addition to providing the hospital and MedStar with useful suggestions about possible improvements.

 

HAVE MORE QUESTIONS? CLICK HERE

We Want To Know is funded by the Agency for Healthcare Research and Quality (Grant #1R18HS022757:K.M. Mazor PI). The project is a partnership between MedStar Health, MedStar Health Research Institute, and Investigators from the University of Massachusetts Medical School and the University of Washington.

 

We Want to Know está financiado por la Agency for Healthcare Research and Quality (Agencia para la Investigación y la Calidad del Cuidado de la Salud), (N.° de subvención 1R18HS022757:K.M. Mazor PI). El proyecto es una colaboración entre MedStar Health, MedStar Health Research Institute (Instituto de Investigación de MedStar Health) e investigadores de la University of Massachusetts Medical School (Facultad de Medicina de la Universidad de Massachusetts) y la University of Washington (Universidad de Washington).